We are studying the super-relaxed state of myosin, with the goal of developing novel therapeutic tools for treatment of contractile and metabolic disorders. In muscle, myosins use the energy from ATP hydrolysis to perform mechanical work during muscle contraction, and to help maintain basal metabolic rate at rest. The myosin super-relaxed state (SRX) in skeletal muscle is hypothesized to play an important role in regulating muscle cell contractility and thermogenesis, yet its physiological role in skeletal muscle remains elusive. The SRX is a biochemical state of myosin with slowed ATP turnover kinetics, due to auto-inhibition of the catalytic domains. Previous work on myosin SRX focused on samples obtained from rabbits and mice. Here, we have used refined quantitative epifluorescence microscopy of fluorescent MANT-ATP to measure single-nucleotide turnover of myosin in skinned skeletal muscle fibers from human donors for the first time. As with most mammalian muscles, the human vastus lateralis is composed of fibers expressing different myosin heavy chain (MHC) isoforms (I, IIA and IIX), which was determined for each fiber tested using gel electrophoresis. Preliminary results show that human skeletal SRX from MHC I fibers have faster ATP turnover compared to MHC II fibers, as previously observed in rabbit muscle fibers. From this work, we are making significant progress toward understanding the biochemical and physiological significance of myosin SRX in human skeletal muscle.
Read full abstract